Items where authors include "Espinasse, A."

Article

Rescigno, P., Porta, N., Finneran, L. et al. (26 more authors) (2024) Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. European Journal of Cancer, 205. 114103. ISSN 0959-8049

Yap, C. orcid.org/0000-0002-6715-2514, Rekowski, J. orcid.org/0000-0002-5207-3864, Ursino, M. orcid.org/0000-0002-5709-4322 et al. (32 more authors) (2023) Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT dose-finding extension (SPIRIT-DEFINE) guidance. BMJ, 383. e076386. ISSN 1759-2151

Yap, C. orcid.org/0000-0002-6715-2514, Solovyeva, O. orcid.org/0000-0001-7828-4099, de Bono, J. orcid.org/0000-0002-2034-595X et al. (32 more authors) (2023) Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT dose-finding extension (CONSORT-DEFINE) guidance. BMJ, 383. e076387. ISSN 0959-8138

Solovyeva, O. orcid.org/0000-0001-7828-4099, Dimairo, M. orcid.org/0000-0002-9311-6920, Weir, C.J. orcid.org/0000-0002-6494-4903 et al. (20 more authors) (2023) Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study. BMC Medicine, 21 (1). 246. ISSN 1741-7015

Espinasse, A. orcid.org/0000-0002-1271-302X, Solovyeva, O., Dimairo, M. orcid.org/0000-0002-9311-6920 et al. (13 more authors) (2023) SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol. BMJ Open, 13. e068173. ISSN 2044-6055